Colgate-Palmolive Company (CL)
Colgate-Palmolive (CL) Q2 Earnings and Revenues Top Estimates
Colgate-Palmolive (CL) came out with quarterly earnings of $0.99 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.92 per share a year ago.
Colgate-Palmolive Sales Rise Despite Choppy Backdrop
Colgate-Palmolive recorded higher sales in the second quarter, despite a choppy consumer environment.
Colgate's Pre-Q2 Earnings: What's Likely to Shape the Results?
CL's Q2 results are likely to show sales and EPS growth, supported by emerging markets, innovation and Hill's, while inflation pressures margins.
5 Dividend Kings Continued to Pay and Raise Dividends Through Every Market Crash Since Black Monday
Black Monday was on Monday, October 19, 1987, almost 40 years ago, and market veterans and long-time investors usually mention one important item: nobody really saw it coming or expected it.
Colgate-Palmolive (CL) Earnings Expected to Grow: Should You Buy?
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble vs Colgate-Palmolive: Two Consumer Giants, Two Strategies, One Invests, Other Optimizes
Procter & Gamble (NYSE:PG | PG Price Prediction) and Colgate-Palmolive (NYSE:CL) both posted top and bottom line beats in their most recent quarters.
Will Colgate-Palmolive (CL) Beat Estimates Again in Its Next Earnings Report?
Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Colgate Stock Rises 17% in 6 Months: Buy or Wait for a Pullback?
CL stock's strength reflects solid momentum, but inflation, North America softness and a premium valuation could keep new buyers waiting.
Procter & Gamble vs. Colgate-Palmolive: One Dividend Giant Stands Above the Rest
Procter & Gamble (NYSE:PG | PG Price Prediction) and Colgate-Palmolive (NYSE:CL) both just reported, and the earnings reports sharpened a debate dividend investors have been having for years.
Will Colgate's Strategic Efforts and Innovation Bolster Growth?
CL leverages pricing power, premium innovation and productivity initiatives to drive growth, expand margins and strengthen brand momentum.
Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today
Procter & Gamble (NYSE:PG | PG Price Prediction) is the household name every retirement portfolio reaches for when markets get choppy, and its $350.4 billion market cap makes it the default consumer defensive trade on every desk.
3 Dividend Kings With Income, Stability, and a Possible Catalyst
Many market analysts believe the current environment of entrenched inflation and higher-for-longer interest rates will be a headwind on the economy into 2027. That combination has made dividend stocks less attractive in recent years.
